Modafinil benefits are proven only for one licensed use in the UK: reducing excessive sleepiness in adults with narcolepsy. Studies in healthy people show small, mixed effects on some thinking tasks, mostly after a single dose in a lab. Modafinil is not licensed as a “smart drug”, and taking it this way carries real health and legal risks.
Key facts
- What it is: A wakefulness-promoting medicine.
- Licensed use (UK): Excessive sleepiness associated with narcolepsy, with or without cataplexy, in adults.
- Legal status: Prescription-only medicine (POM). Supplying it without a valid prescription is a criminal offence.
- Needs a prescription: Yes
- Last checked: November 2026
Modafinil is often described online as a “smart drug” or nootropic that sharpens focus. This guide looks at what the research found, what it cannot tell you, and what UK regulators say. For an overview of the medicine itself, see our complete guide to modafinil.
Does modafinil have benefits?
Yes, for the people it is licensed for. The UK Summary of Product Characteristics (SmPC) for modafinil lists one use. That is excessive sleepiness associated with narcolepsy, with or without cataplexy, in adults.
For these people, the benefit is staying awake through the day. That is a medical problem with a diagnosis, and a specialist weighs the benefits against the risks. You can read more on our narcolepsy and excessive sleepiness hub.
The “smart drug” claim is a different question. It asks whether modafinil improves thinking in healthy people who are not sleep deprived. The evidence for that is far weaker, and the licence does not cover it.
Why is modafinil called a “smart drug”?
The label grew from student use, news stories and films such as Limitless, which showed a fictional pill that boosted the brain. Modafinil is not that pill. No study has shown it turns an average person into a much sharper one.
Regulators noticed this use more than 15 years ago. When the European Medicines Agency (EMA) reviewed modafinil, its referral page noted that modafinil had often been used for conditions it was not indicated for. It also said data on misuse by university students were being collected.
That review, started at the UK regulator’s request in May 2009, ended with modafinil restricted to narcolepsy. The EMA found the benefits outweighed the risks only for that condition. The risks it weighed included psychiatric effects, serious skin reactions and heart problems.
What does the research on modafinil in healthy people show?
The results point in different directions. Here are three pieces of research that are often quoted, and what each one really found.
The Oxford and Harvard review (2015)
Researchers from the University of Oxford and Harvard Medical School reviewed studies of modafinil in healthy people who were not sleep deprived. A Sleep Review report on the review from August 2015 says they found 24 studies published between January 1990 and December 2014.
The review reported that modafinil improved decision-making and planning. It made no difference to working memory or flexibility of thought.
The authors also said ethical questions must be considered. The studies were done in controlled settings, which is very different from everyday use.
A randomised trial that found slower responses (2014)
A randomised controlled trial published in PLOS ONE in November 2014 gave 64 healthy volunteers either one dose of modafinil or a placebo. They then completed a sentence task that tests planning and self-control.
People who took modafinil took longer to respond than those on placebo. They were no more accurate. The authors said this may help define the limits of modafinil as a possible cognitive enhancer.
A survey of people using it when it wasn’t prescribed for them (2020)
A 2020 online survey in PLOS ONE looked at 219 people who said they used modafinil outside a prescription. They were recruited from online forums in 2016. Most were male and university educated, with an average age of 27.
Users said they noticed more benefits than risks, and saw it as safe. But they also reported more illicit drug use and more psychiatric diagnoses than expected in the general population. A survey like this measures beliefs, not real effects, and cannot show cause and effect.
The same paper summarises earlier research. It notes that modafinil’s effects on thinking appear greater in people who are sleep deprived. It also notes they may be stronger when someone’s starting performance is lower.
What the studies can’t tell you
Most studies in healthy people test a single dose in a lab. They tell you little about taking it repeatedly, for weeks of revision, or at work.
- Small, uneven effects: some tasks improve, others do not change, and one trial found slower responses.
- Lab tests are not real life: doing better on a computer task is not the same as better exam marks or job performance.
- Short follow-up: controlled studies cannot show rare or long-term harms, which regulators learn about from wider use.
- Unknown products: tablets sold outside the legal supply chain may not contain what the study used, or anything like it.
So the honest answer to “does modafinil make you smarter?” is no. At most, it may help with some tasks in some people, mainly when they are tired.
What are the risks of modafinil?
The SmPC sets out safety warnings that apply to everyone who takes modafinil, including people who have a prescription. These are why a doctor checks your health first and follows you up.
| Risk | What the UK SmPC says |
|---|---|
| Serious skin rash | Modafinil should be stopped at the first sign of rash and not restarted. |
| Mental health | If psychiatric symptoms develop, it should be stopped and not restarted. |
| Heart | An ECG (heart tracing) is recommended in all patients before treatment starts. |
| Contraception | It can make hormonal contraception less effective, during treatment and for two months after stopping. |
| Dependence | Studies have shown a potential for dependence. |
Headache is the most common side effect, affecting about 21% of patients in the SmPC. Others include nervousness, trouble sleeping, anxiety, dizziness, a fast heartbeat and chest pain. See our guides to modafinil side effects and modafinil, your heart and blood pressure.
Modafinil also interacts with other medicines. Read about modafinil and alcohol, caffeine and contraception, and whether modafinil is addictive.
Modafinil, UK law and fake or unlicensed supply
In September 2016 the MHRA warned new students to avoid modafinil. Its press release “Freshers warned to be smart and avoid Modafinil” said modafinil is licensed for specific medical conditions, not as a boost during exams.
The MHRA said cognitive enhancers carry a risk of dependence, heart problems and psychosis. It added that supplying prescription-only medicines without a valid prescription is a criminal offence, and websites offering them are acting illegally.
The same release reported that nearly 5,000 websites had been shut down that year. An international operation, Operation Pangea, had also seized more than 31,000 doses of narcolepsy medication.
A year later the MHRA warned students again about self-prescribing. In its 2017 press release, it said medicines from outside the regulated supply chain may have the wrong active ingredient, none at all, or the wrong dose. It also warned of card fraud and identity theft.
For more on the legal position, see is modafinil legal in the UK. To check a pharmacy is genuine, see how to check an online pharmacy is legitimate.
Why online prescribers must take extra care
UK regulators treat medicines that can be misused as needing extra safeguards when prescribed remotely.
The General Pharmaceutical Council (GPhC) strengthened its guidance for online pharmacies in February 2025. Prescribers cannot base decisions on an online questionnaire alone, and there are further safeguards for medicines liable to misuse.
A legitimate service will ask about your health, may contact your GP, and will say no if modafinil is not right for you. Prescribing it as a study aid would be outside its UK licence.
If tiredness or focus is holding you back
Feeling constantly tired, or struggling to stay awake in the day, is worth taking to your GP. It can have medical causes, and narcolepsy is one of them. A proper assessment is the route to the right treatment, which may or may not include medicine.
If you already take modafinil on prescription, take it exactly as your prescriber tells you. Do not share it, and do not take more to get a stronger effect. Talk to your prescriber if it no longer seems to help.
If you have been taking modafinil that was not prescribed for you, you can speak to your GP or pharmacist in confidence. They can check your health and help you stop safely.
When to get help
Call 999 or go to A&E if you or someone else has chest pain, a very fast or irregular heartbeat, a fit, or swelling of the face, lips or throat after taking modafinil.
Stop taking modafinil and get urgent medical advice (call your doctor or NHS 111) if you get a skin rash, blisters, peeling skin or mouth ulcers, or new or worse low mood, anxiety, aggression, hallucinations or thoughts of harming yourself.
You can report side effects, and suspected fake medicines, to the MHRA through the Yellow Card scheme.
Frequently asked questions
What did the main modafinil study find?
The most cited review, from Oxford and Harvard researchers in 2015, looked at 24 studies in healthy people. It found improved decision-making and planning, but no change in working memory or flexible thinking. A 2014 trial found slower responses with no gain in accuracy.
Is modafinil a nootropic?
It is sometimes sold or described as one, but in the UK modafinil is a prescription-only medicine. It is licensed only for excessive sleepiness in adults with narcolepsy, not for boosting thinking.
Is modafinil the “Limitless” drug?
No. The pill in the film is fictional. Research on modafinil in healthy people shows small and mixed effects on some tasks, not a dramatic boost to intelligence.
Does modafinil make you smarter?
No. It does not raise intelligence. Some studies found small benefits on certain tasks, mostly after one dose in a lab, while others found no benefit or slower responses.
Is it safe to try modafinil for exams?
No. The MHRA has warned students not to use it as a study aid. It carries risks to mental health, the heart and the skin, and products sold illegally online may contain the wrong ingredient or dose.
References
- Modafinil 100 mg tablets – Summary of Product Characteristics, electronic medicines compendium (emc), accessed November 2026
- Modafinil – referral, European Medicines Agency, accessed November 2026
- Review: modafinil enhances cognition in the non-sleep-deprived, Sleep Review, 24 August 2015, accessed November 2026
- Mohamed AD, Lewis CR. Modafinil increases the latency of response in the Hayling Sentence Completion Test in healthy volunteers: a randomised controlled trial, PLOS ONE, 2014;9(11):e110639, accessed November 2026
- Teodorini RD, Rycroft N, Smith-Spark JH. The off-prescription use of modafinil: an online survey of perceived risks and benefits, PLOS ONE, 2020;15(2):e0227818, accessed November 2026
- Freshers warned to be smart and avoid Modafinil, MHRA, 26 September 2016, accessed November 2026
- Freshers warned against self-prescribing: you’re not doctors yet, MHRA, 26 September 2017, accessed November 2026
- Online pharmacies to strengthen safeguards to prevent unsafe supply of medicines, General Pharmaceutical Council, 4 February 2025, accessed November 2026
This article is for information only and does not replace advice from your doctor or pharmacist. Read our medical disclaimer.